PUBLISHER: The Business Research Company | PRODUCT CODE: 1942458
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942458
Blood group typing is a method employed to determine an individual's blood type, facilitating safe blood donation or transfusion.
Key types of blood group typing include antibody screening, cross-matching tests, ABO tests, antigen typing, and human leukocyte antigen (HLA) typing. Antibody screening tests are conducted in clinical laboratories or blood banks to identify unexpected antibodies, such as alloantibodies, in the serum related to non-ABO blood group antigens. Cross-matching tests are integral to blood compatibility testing before transfusions. HLA typing, a genetic test, identifies variations in immune system proteins, commonly used for matching patients and donors in bone marrow or cord blood transplants. ABO tests categorize blood types into A, B, AB, or O. Antigen tests, utilizing immunoassays, detect specific viral antigens and are employed in the diagnosis of respiratory pathogens like influenza viruses. Products used for blood group typing include instruments, reagents, and kits, employing techniques such as serology tests and molecular tests. Blood group typing finds application in hospital-based laboratories, independent laboratories, and blood banks.
Tariffs are impacting the blood group typing market by increasing costs of imported reagents, diagnostic kits, analyzers, and laboratory automation components. Hospital laboratories and blood banks in North America and Europe are most affected due to dependence on imported consumables, while Asia-Pacific faces pricing pressure on export-oriented diagnostic manufacturing. These tariffs are raising testing costs and procurement budgets. However, they are also encouraging local reagent manufacturing, regional kit production, and domestic laboratory equipment assembly.
The blood group typing market research report is one of a series of new reports from The Business Research Company that provides blood group typing market statistics, including blood group typing industry global market size, regional shares, competitors with a blood group typing market share, detailed blood group typing market segments, market trends and opportunities, and any further data you may need to thrive in the blood group typing industry. This blood group typing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The blood group typing market size has grown rapidly in recent years. It will grow from $3.46 billion in 2025 to $3.93 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to expansion of blood transfusion procedures, growth in hospital laboratory services, rising surgical volumes, increased blood donation screening, standardization of transfusion protocols.
The blood group typing market size is expected to see rapid growth in the next few years. It will grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing adoption of molecular typing techniques, rising demand for rapid compatibility testing, expansion of automated laboratory workflows, growing investments in transfusion safety systems, technological advances in blood group diagnostics. Major trends in the forecast period include increasing adoption of automated blood typing systems, rising demand for high-throughput testing platforms, growing use of molecular blood group typing, expansion of advanced reagent and kit solutions, enhanced focus on transfusion safety.
The blood group typing market experienced growth during the historic period, driven by a notable increase in the number of blood donations and transfusions. Various non-profit organizations, government entities, and agencies have been actively promoting the significance of blood donations through awareness campaigns. This surge in blood donations has led to an augmented demand for blood group typing, enabling donors to ascertain their blood type. For instance, in February 2024, according to CDC (Centers for Disease Control and Prevention), U.S-based government agency reported that, in 2024, there are approximately 7 million blood donors and more than 14 million units of blood transfused annually in the United States. The upswing in blood donations and transfusions has thus been a significant factor propelling the growth of the blood typing market.
Leading companies in the blood group typing market are focusing on developing innovative products using advanced technologies like next-generation sequencing (NGS) to improve the accuracy and efficiency of blood typing processes. NGS allows for a detailed analysis of genetic variations in blood group antigens, providing more precise and comprehensive blood group typing. For example, in April 2023, Metropolis Healthcare Limited, an India-based healthcare company, introduced the NextGen HLA Typing Test. This test leverages NGS technology to enhance the precision of human leukocyte antigen (HLA) typing for organ transplants, improving compatibility assessments between donors and recipients, which is essential for successful transplant outcomes.
In March 2023, Werfen, S.A., a Spain-based company operating in blood group typing, hemostasis, and transfusion, completed the acquisition of Immucor Inc. for approximately US$2 billion. This strategic move expanded Werfen's position as a reference business in the specialized diagnostics market and broadened its diagnostic solutions for hospitals and clinical laboratories. The acquisition integrated Immucor Inc., a U.S.-based company specializing in blood group typing, into Werfen's portfolio, strengthening the company's range by adding Transfusion and Transplant product lines to its existing Hemostasis, Acute Care, and Autoimmunity business lines. The acquisition is a testament to Werfen's commitment to enhancing its capabilities and offerings in the blood gas and electrolyte analyzer market.
Major companies operating in the blood group typing market are Grifols S.A., Bio-Rad Laboratories Inc., Immucor Inc., Ortho-Clinical Diagnostics Inc., Quotient Limited, AXO Science SAS, Agena Bioscience Inc., Merck KGaA, Beckman Coulter Inc., DIAGAST SAS, Thermo Fisher Scientific Inc., One Lambda Inc., Tulip Diagnostics (P) Ltd., Guangzhou Wondfo Biotech Co. Ltd., DiaSorin S.p.A., Grifols Diagnostic Solutions Inc., Hemo bioscience Inc., Medion Diagnostics GmbH, ZenTech S.A., BioMedomics Inc., Lifespan Diagnostics LLC
North America was the largest region in the blood group typing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the blood group typing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the blood group typing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The blood group typing market consists of sale of serology reagents, gel systems, lateral flow rapid technology, and blood group genotyping products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Blood Group Typing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses blood group typing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for blood group typing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood group typing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.